Survey findings show healthcare providers continue to request unrecommended testing panels due to family requests and clinical habit.
RT’s Three Key Takeaways:
- High Awareness of Inaccuracy: A survey presented at an annual allergy meeting revealed that 85% of clinicians knew food allergy panels often produce false-positive results, yet they ordered them anyway.
- Family Request Pressures: Roughly 21% of surveyed healthcare providers ordered food allergy panels at the direct request of a patient or family, rather than for clinical necessity.
- Risks of Unwarranted Avoidance: False positives can prompt unnecessary food eli
Eighty-five percent of surveyed clinicians know that food allergy panel testing often results in false positives—yet they kept ordering the test anyway, according to research presented at ACAAI 2026.
Food allergy panel testing checks a person’s blood for allergic proteins produced by the immune system, or immunoglobulin E antibodies, to many foods at once. These commercially available panels frequently come back with “false positives,” indicating the presence of allergic proteins, or sensitization, to foods even when a clinical food allergy may not exist.
“Most of the clinicians we surveyed already knew these tests could lead to false positive results, but many still ordered them despite current guidelines advising against their use,” said allergist-immunologist Katelyn Wong, MD, senior author of the study and ACAAI member. “False positive results can lead families to cut out foods that were never actually unsafe, cause unnecessary stress, and add extra costs. At one hospital system alone, more than 1,700 of these panels were ordered in a single year.”
Researchers surveyed 300 clinicians who ordered at least one food allergy panel in 2024. Forty-three completed the anonymous survey, most of them primary care doctors, nurse practitioners, and physician assistants.
Several findings stood out:
- 85% of clinicians knew these panels often give false positive results — but ordered them anyway.
- Many clinicians had ordered food allergy panels for unvalidated indications such as food allergies, hives, and eczema.
- Some clinicians had ordered the test simply because a patient or family asked for it, not because it was medically needed.
- In one survey question about a patient with eczema and a family history of food allergy, nurse practitioners and physician assistants were more likely than physicians to think a food allergy panel was the right choice, even though experts do not recommend this.
The gap between knowing the downsides of the panels and knowing expert recommendations may help explain why these panels are ordered so often, even though experts advise against them.
When a food allergy panel has a false positive result, families may end up avoiding foods that were never actually a problem. This can make mealtimes stressful, limit a child’s diet without reason, and add worry the family didn’t need. It can also mean additional visits and unnecessary costs. Moreover, avoidance of food allergens can increase the risk of developing food allergies.
Study Info
EXPLORING ORDERING CLINICIANS’ PERSPECTIVES OF FOOD ALLERGY PANELS
R285
M. Nguyen*, K. Brady, K. Wong, New Haven, CT.
Introduction: Broad food allergy (FA) panels are over-ordered for unvalidated indications, with over 1,700 ordered at our institution in 2024. Professional societies advise against their use due to the negative consequences of unnecessary food avoidance, psychological stress, and financial burden. This study aimed to elucidate ordering clinicians’ rationale and understanding of these panels.
Methods: 300 clinicians who had ordered at least one FA panel in 2024 were contacted via email or Epic message to participate in a voluntary, anonymous survey. Results were analyzed using Qualtrics and Prism. This study was exempted by IRB.
Results: 43 clinicians completed the survey. Most were generalists (55% internal medicine, 27% pediatrics) and physicians (MD/DO 58% vs NP/PA 40%). The mean length of practice was 16 years (standard deviation=10). Most learned about FA panels after training (44%). 85% recognized that FA panels have high false positive rates. Clinicians reported appropriate FA panel indications included IgE-mediated FA (38%), urticaria (29%) and eczema (14%). Clinicians had previously ordered FA panels for IgE-mediated FA (24%), patient/family request (21%), and urticaria (20%). When asked to evaluate eczema triggers in a patient with family history of FA, 30% of MD/DOs and 63% of NP/PAs agreed that FA panel would be indicated (Χ2 (1, N = 43) = 3.946, p = 0.047).
Conclusion: This survey identified knowledge gaps regarding appropriate indications for FA panels despite awareness of high false positive rates, suggesting that targeted educational efforts may prove helpful to reduce the use of FA panels.